High prevalence of breast cancer in patients with benign thyroid diseases

Journal of Endocrinological Investigation

Volumn 34, Issue 5, 2011, Pages 349-352

  Muller, I ^a   Pinchera, A ^a   Fiore, E ^a   Belardi, V ^a   Rosellini, V ^a   Giustarini, E ^a   Giani, C ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Benign thyroid disease; Breast cancer; Nodular goiter; Thyroid autoimmunity

Indexed keywords

ESTROGEN; THYROID ANTIBODY;

ADULT; AGE; ANTIBODY BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER RISK; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; NODULAR GOITER; OBESITY; POPULATION RESEARCH; PREVALENCE; THYROID DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; MIDDLE AGED; THYROID DISEASES; THYROID GLAND;

EID: 79960227556     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7141     Document Type: Article

References (33)

1. Chalstrey U, Benjamin B. High incidence of breast cancer in thyroid cancer patients. Br J Cancer 1966, 20: 670-5.
2. Myhill J, Reeve TS, Hales IB. Thyroid function in breast cancer. Acta Endocrinol (Copenh) 1966, 51: 290-300.
3. Sicher K, Waterhouse JA. Thyroid activity in relation to prognosis in mammary cancer. Br J Cancer 1967, 21: 512-8.
4. Goldman MB. Thyroid diseases and breast cancer. Epidemiol Rev 1990, 12: 16-28.
5. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990, 50: 2283-9. (Pubitemid 20134482)
6. Smyth PP. Thyroid disease and breast cancer. J Endocrinol Invest 1993, 16: 396-401. (Pubitemid 23197254)
7. Turken O, Narln Y, Demlrbas S, et al. Breast cancer in association with thyroid disorders. Breast Cancer Res 2003, 5: R110-3.
8. Mittra I, Perrin J, Kumaoka S. Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J 1976, 1: 257-9.
9. Ito K, Maruchi N. Breast cancer in patients with Hashimoto's thyroiditis. Lancet 1975, 2: 1119-21.
10. Rasmusson B, Feldt-Rasmussen U, Hegedüs L, Perrild H, Bech K, Høier-Madsen M. Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 1987, 23: 553-6. (Pubitemid 17057387)
11. Maruchi N, Annegers JF, Kurland LT. Hashimoto's thyroiditis and breast cancer. Mayo Clin Proc 1976, 51: 263-5.
12. Giani C, Fierabracci P, Bonacci R, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 1996, 81: 990-4. (Pubitemid 26083958)
13. Giustarini E, Pinchera A, Fierabracci P, et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006, 154: 645-9. (Pubitemid 43810849)
14. Fiore E, Giustarini E, Mammoli C, et al. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer. J Endocrinol Invest 2007, 30: 734-8. (Pubitemid 350238198)
15. Garner CN, Ganetzky R, Brainard J, et al. Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery 2007, 142: 806-13. (Pubitemid 350184096)
16. Sioka C, Fotopoulos A. Association of thyroid cancer with breast cancer. Surgery 2009, 145: 123-4.
17. Agarwal DP, Soni TP, Sharma OP, Sharma S. Synchronous malignancies of breast and thyroid gland: a case report and review of literature. J Cancer Res Ther 2007, 3: 172-3. (Pubitemid 350293677)
18. Weiss HA, Brinton LA, Potischman NA, et al. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 1999, 28: 816-23. (Pubitemid 29525019)
19. Simon MS, Tang MT, Bernstein L, et al. Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev 2002, 11: 1574-8.
20. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993, 22: 1000-9. (Pubitemid 24025676)
21. De Angelis R, Grande E, Inghelmann R, et al. Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 2007, 93: 392-7.
22. Rago T, Chiovato L, Grasso L, Pinchera A, Vitti P. Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dsfunction in apparently healthy subjects. J Endocrinol Invest 2001, 24: 763-9. (Pubitemid 33120970)
23. Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 1991, 72: 209-13. (Pubitemid 21921677)
24. Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 1999, 84: 561-6. (Pubitemid 29075684)
25. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000, 6: 871-8. (Pubitemid 30644744)
26. nd, Brooks AD, Eskin BA, Johannes GJ. Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine. Int J Med Sci 2008, 5: 189-96.
27. Bonacci R, Pinchera A, Fierabracci P, Gigliotti A, Grasso L, Giani C. Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue. J Endocrinol Invest 1996,19: 159-64. (Pubitemid 26162608)
28. Giani C, Campani D, De Negri F, et al. Interference of thyroperoxidase on immuno-cytochemical determination of steroid receptors in thyroid tissue. J Endocrinol Invest 1993, 16: 37-43 (Pubitemid 23096267)
29. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 2001, 86: 1072-7. (Pubitemid 32322984)
30. Rajoria S, Suriano R, Shanmugam A, et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 2010, 20: 33-41.
31. Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 2007, 109: 1972-9. (Pubitemid 46744190)
32. Holm LE, Hall P, Wiklund K, et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991, 83: 1072-7.
33. Hoffman DA, McConahey WM, Fraumeni JF Jr, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 1982, 11: 218-24. (Pubitemid 12019143)